Tyme Technologies Inc (NASDAQ:TYME) Expected to Post Earnings of -$0.06 Per Share

Brokerages forecast that Tyme Technologies Inc (NASDAQ:TYME) will report earnings per share of ($0.06) for the current fiscal quarter, according to Zacks Investment Research. Zero analysts have issued estimates for Tyme Technologies’ earnings. Tyme Technologies posted earnings per share of ($0.08) during the same quarter last year, which suggests a positive year over year growth rate of 25%. The business is scheduled to issue its next quarterly earnings results on Monday, February 10th.

According to Zacks, analysts expect that Tyme Technologies will report full year earnings of ($0.21) per share for the current year. For the next fiscal year, analysts forecast that the company will report earnings of ($0.23) per share. Zacks’ earnings per share calculations are an average based on a survey of analysts that follow Tyme Technologies.

Tyme Technologies (NASDAQ:TYME) last posted its quarterly earnings results on Monday, November 4th. The company reported ($0.04) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.06) by $0.02.

A number of equities analysts have recently weighed in on TYME shares. ValuEngine raised shares of Tyme Technologies from a “hold” rating to a “buy” rating in a research note on Wednesday, October 2nd. HC Wainwright initiated coverage on shares of Tyme Technologies in a report on Monday, August 12th. They issued a “buy” rating for the company. Finally, Zacks Investment Research upgraded shares of Tyme Technologies from a “hold” rating to a “buy” rating and set a $1.50 price objective for the company in a report on Friday, November 8th.

In related news, major shareholder Michael Demurjian sold 20,000 shares of the company’s stock in a transaction on Monday, September 23rd. The shares were sold at an average price of $1.67, for a total value of $33,400.00. Insiders sold 260,000 shares of company stock valued at $2,175,600 over the last quarter. 27.17% of the stock is currently owned by corporate insiders.

A number of large investors have recently modified their holdings of TYME. Squarepoint Ops LLC bought a new stake in Tyme Technologies in the third quarter worth $71,000. Morgan Stanley boosted its holdings in Tyme Technologies by 187.8% during the second quarter. Morgan Stanley now owns 139,579 shares of the company’s stock valued at $170,000 after acquiring an additional 91,081 shares during the period. Perkins Capital Management Inc. boosted its holdings in Tyme Technologies by 77.0% during the third quarter. Perkins Capital Management Inc. now owns 142,500 shares of the company’s stock valued at $170,000 after acquiring an additional 62,000 shares during the period. Paloma Partners Management Co bought a new stake in Tyme Technologies during the second quarter valued at about $238,000. Finally, Bank of New York Mellon Corp boosted its holdings in Tyme Technologies by 5.9% during the second quarter. Bank of New York Mellon Corp now owns 306,199 shares of the company’s stock valued at $374,000 after acquiring an additional 17,173 shares during the period. Hedge funds and other institutional investors own 12.93% of the company’s stock.

Shares of NASDAQ TYME traded up $0.03 during mid-day trading on Wednesday, reaching $1.15. The company had a trading volume of 189,100 shares, compared to its average volume of 621,117. Tyme Technologies has a twelve month low of $0.92 and a twelve month high of $4.64. The stock has a market capitalization of $125.38 million, a PE ratio of -3.59 and a beta of 0.34. The stock’s 50 day moving average is $1.25 and its 200-day moving average is $1.24.

About Tyme Technologies

Tyme Technologies, Inc, a clinical-stage biotechnology company, develops novel cancer therapeutics. It is developing SM-88, a combination therapy based on dysfunctional metyrosine derivatives in Phase II development for metastatic pancreatic cancer and biomarker-recurrent prostate cancer. The company was founded in 2011 and is headquartered in New York, New York.

Read More: Understanding dividend yield and dividend payout ratio

Get a free copy of the Zacks research report on Tyme Technologies (TYME)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Tyme Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tyme Technologies and related companies with MarketBeat.com's FREE daily email newsletter.